| 13.91 Data as of May 24 |  -0.08 / -0.57%Today’s Change | 11.15 Today|||52-Week Range 16.39 | -2.32% Year-to-Date |
| Here's Why Endologix's Latest Report Might Worry You May 22 / MotleyFool.com | Here's 1 Reason Endologix Looks Weak May 13 / MotleyFool.com |
| Previous close | 13.99 |
| Today’s open | 13.89 |
| Day’s range | 13.72 - 13.94 |
| Volume | 221,115 |
| Average volume (3 months) | 422,084 |
| Market cap | $873.5M |
| Dividend yield | -- |
| Earnings growth (last year) | -17.65% |
| Earnings growth (this year) | +38.46% |
| Earnings growth (next 5 years) | +95.60% |
| Revenue growth (last year) | +27.01% |
| P/E ratio | NM |
| Price/Sales | 8.04 |
| Price/Book | 9.21 |
| Today’s change | Today’s % change | |
|---|---|---|
| RIGLRigel Pharmaceutical... | +0.07 | +1.51% |
| VSIVitamin Shoppe Inc | -0.04 | -0.09% |
| LFVNLifeVantage Corp | 0.00 | 0.00% |
| NATRNature's Sunshine Pr... | +0.08 | +0.52% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $105.9M |
| Annual profit (last year) | -$35.8M |
| Net profit margin | -33.77% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer John D. McDermott, MBA |
Vice President- Operations Todd G. Abraham |
Corporate headquarters Irvine, California |
.
